APOJECT, created in 1997 (United Kingdom), from 316 sister brands and 4958 competing brands. APOJECT is owned by STADA ARZNEIMITTEL, listed on the stock exchange of Etats-Unis Its International Securities Identification Number (ISIN) is DE0007251803. APOJECT is part of the Drug Manufacturers activity sector.